Mr. Scavilla said, “I am honored to join the Board and continue to drive forward Dentsply Sirona’s mission of transforming and advancing innovation. As a longtime executive in the healthcare industry, ...

“We are pleased to welcome Mike and Dan ... Mr. Scavilla has served as President and Chief Executive Officer of Globus Medical, Inc. (NYSE: GMED) since April 2022, leading Globus Medical ...

"We are pleased to welcome Mike and Dan, two proven leaders with skillsets ... Mr. Scavilla has served as President and Chief Executive Officer of Globus Medical, Inc. (NYSE: GMED) since April 2022, ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...

Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...

Stifel Nicolaus boosted their price objective on Globus Medical from $80.00 to $92.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Roth Mkm boosted their price ...

Buying $100 In GMED: If an investor had bought $100 of GMED stock 10 years ago, it would be worth $356.36 today based on a price of $86.88 for GMED at the time of writing.